Cost of medical care for HIV‐infected patients within a regional population from 1997 to 2006
暂无分享,去创建一个
M J Gill | H B Krentz | M. Gill | HB Krentz
[1] M. Youle,et al. Health economics in HIV disease. A review of the European literature. , 1999, PharmacoEconomics.
[2] J. Knodel,et al. The impact of the AIDS epidemic on older persons , 2002, AIDS.
[3] M C Weinstein,et al. The cost effectiveness of combination antiretroviral therapy for HIV disease. , 2001, The New England journal of medicine.
[4] M. Weinstein,et al. Routine human immunodeficiency virus testing: an economic evaluation of current guidelines. , 2005, The American journal of medicine.
[5] S. Gingues,et al. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS‐defining cancers in Southern Alberta , 2006, HIV medicine.
[6] M. Gill,et al. The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[7] J Darbyshire,et al. CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.
[8] The oncology impact of highly active antiretroviral therapy , 2007, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
[9] B. Gazzard,et al. The cost of antiretroviral drugs and influence on prescribing policies , 2006, International journal of STD & AIDS.
[10] D. McCaffrey,et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. , 2001, The New England journal of medicine.
[11] B. Thiers,et al. CD4+ Count–Guided Interruption of Antiretroviral Treatment , 2007 .
[12] Richard D Moore,et al. Costs of HIV medical care in the era of highly active antiretroviral therapy. , 1999, AIDS.
[13] M. Gill,et al. The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection , 2004, HIV medicine.
[14] Atlanta,et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[15] R. Colebunders,et al. Direct costs of health care for HIV/AIDS patients in Belgium , 2001, AIDS care.
[16] Costing implications of recent treatment interruption studies. , 2006, AIDS.
[17] T. Parikh,et al. The High Cost of Medical Care , 2008 .
[18] E. Tacconelli,et al. Older HIV-positive patients in the era of highly active antiretroviral therapy: changing of a scenario , 2003, AIDS.
[19] M. Youle,et al. Assessing the cost‐effectiveness of HAART for adults with HIV in England , 2001, HIV medicine.
[20] Jerome H. Carter,et al. Distribution of health care expenditures for HIV-infected patients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[21] M. Weinstein,et al. Should resistance testing be performed for treatment-naive HIV-infected patients? A cost-effectiveness analysis. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[22] E. Beck,et al. The cost of HIV treatment and care. A global review. , 2001, PharmacoEconomics.
[23] E. Mokotoff,et al. Characteristics of HIV infection in patients fifty years or older in Michigan. , 2001, AIDS patient care and STDs.
[24] M. Gill,et al. Longitudinal assessment (1995–2003) of hospitalizations of HIV‐infected patients within a geographical population in Canada , 2006, HIV medicine.
[25] M. Suarez‐Almazor,et al. Retention in care: a challenge to survival with HIV infection. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] A. Levy,et al. The direct costs of HIV/AIDS care. , 2006, Lancet. Infectious Diseases (Print).
[27] Richard D Moore,et al. Treatment of HIV infection in the older patient , 2004, Expert review of anti-infective therapy.
[28] Richard D Moore,et al. Hospital and Outpatient Health Services Utilization Among HIV-Infected Adults in Care 2000–2002 , 2005, Medical care.
[29] M. Gill,et al. Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program , 2005 .
[30] Milton C Weinstein,et al. The survival benefits of AIDS treatment in the United States. , 2006, The Journal of infectious diseases.
[31] J. Graf von der Schulenburg,et al. Direct costs for the treatment of HIV-infection in a German cohort after the introduction of HAART. , 2002, European journal of medical research.
[32] Anke Richter,et al. HIV Antiretroviral Treatment: Early Versus Later , 2005, Journal of acquired immune deficiency syndromes.
[33] E. Beck,et al. The cost-effectiveness of highly active antiretroviral therapy, Canada 1991–2001 , 2004, AIDS.